XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash $ 819,024 $ 4,349,837
Accounts receivable, net 2,057,546 2,213,040
Inventories, net 6,936,980 6,685,847
Prepaid and other current assets 548,561 1,029,548
Notes receivable 185,000 185,000
Total current assets 10,547,111 14,463,272
Property and equipment, net 799,892 791,155
Right-of-use asset 3,525,406 3,952,317
Intangible assets, net 2,615,281 11,507,653
Goodwill 7,402,644 23,179,411
Other assets 265,567 291,066
Total assets 25,155,901 54,184,874
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 3,062,794 1,845,135
Accrued liabilities 1,944,352 1,680,706
Promissory note 4,504,500 287,381
Contract liabilities 226,316 496,390
Current portion of lease liabilities 901,925 628,113
Current portion of COVID loan 391,545 446,456
Total current liabilities 11,031,432 5,384,181
Long-term portion of lease liabilities 2,721,743 3,161,703
Long-term portion of COVID loan 489,037 446,813
Defined benefit plan obligation 216,133 106,163
Long-term portion of promissory note 1,861,539
Total liabilities 14,458,345 10,960,399
COMMITMENTS AND CONTINGENCIES (NOTE 13)
STOCKHOLDERS’ EQUITY:    
Preferred Stock, $0.001 par value, 25,000,000 shares authorized: Preferred Stock, Series F Convertible, $0.001 par value, 35,000 shares authorized, 6,075 shares issued and outstanding as of December 31, 2023, and 5,863 shares issued and outstanding as of December 31, 2022, respectively 6 6
Common Stock, $0.001 par value, 250,000,000 shares authorized, 140,520,163 and 88,466,613 shares issued and outstanding as of December 31, 2023 and 2022, respectively 140,521 88,467
Additional paid-in capital 176,033,817 154,679,363
Accumulated deficit (165,583,091) (111,553,444)
Accumulated other comprehensive income 106,303 10,083
Total stockholders’ equity 10,697,556 43,224,475
Total liabilities and stockholders’ equity $ 25,155,901 $ 54,184,874